Cowen Prime Advisors LLC Durect Corp Transaction History

Cowen Prime Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.43 - $5.9 $75 - $1,032	175 Added 0.14%	128,187 $74,000
Q2 2022 Aug 01, 2022	BUY	$0.38 - $0.64 $2,394 - $4,032	6,300 Added 5.18%	128,012 $61,000
Q1 2022 May 02, 2022	BUY	$0.55 - $0.98 $4,679 - $8,338	8,509 Added 7.52%	121,712 $82,000
Q4 2021 Feb 08, 2022	BUY	$0.9 - $1.31 $22,072 - $32,127	24,525 Added 27.66%	113,203 $112,000
Q3 2021 Nov 02, 2021	BUY	$1.21 - $1.61 $4,840 - $6,440	4,000 Added 4.72%	88,678 $114,000
Q2 2021 Aug 04, 2021	SELL	$1.6 - $2.02 $69,334 - $87,534	-43,334 Reduced 33.85%	84,678 $138,000
Q2 2020 Aug 01, 2022	BUY	$1.33 - $2.76 $170,255 - $353,313	128,012 New	128,012 $61,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen Prime Advisors LLC with notifications on news.